Background: High-quality management of prostate cancer is needed in the fields of clinics, research, and education. Objective: The objective of this project was to develop the concept of \u201cEuropean Prostate Cancer Centres of Excellence\u201d (EPCCE), with the specific aim of identifying European centres characterised by high-quality cancer care, research, and education. Design, setting, and participants: A task force of experts aimed at identifying the general criteria to define the EPCCE. Discussion took place in conference calls and by e-mail from March 2017 to November 2017, and the final consensus meeting named \u201cEuropean Association of Urology (EAU) Prostate Cancer Centre Consensus Meeting\u201d was held in Barcelona on Novembe...
BACKGROUND: In advanced prostate cancer (APC), successful drug development as well as advances in im...
Multidisciplinary care of prostate cancer is increasingly offered in specialised cancer centres. It ...
OBJECTIVE: To explore preferences in the management of patients with newly diagnosed high-risk prost...
BACKGROUND: High-quality management of prostate cancer is needed in the fields of clinics, research,...
The widely recognised benefits of a multidisciplinary approach to treating cancer may be particularl...
The Prostate Cancer Programme of the European School of Oncology developed the concept of specialise...
The Prostate Cancer Programme of the European School of Oncology developed the concept of specialise...
The Prostate Cancer Programme of the European School of Oncology developed the concept of specialise...
CONTEXT: Phase 3 trials have made major contributions to advances in prostate cancer (PCa). However,...
Background: Multidisciplinary care of prostate cancer is increasingly offered in specialised cancer ...
CONTEXT: Phase 3 trials have made major contributions to advances in prostate cancer (PCa). However...
Background: There is uncertainty in deferred active treatment (DAT) programmes, regarding patient s...
BACKGROUND: There is uncertainty in deferred active treatment (DAT) programmes, regarding patient se...
Background: ECCO Essential Requirements for Quality Cancer Care (ERQCC) are written by experts repre...
Multidisciplinary care of prostate cancer is increasingly offered in specialised cancer centres. It ...
BACKGROUND: In advanced prostate cancer (APC), successful drug development as well as advances in im...
Multidisciplinary care of prostate cancer is increasingly offered in specialised cancer centres. It ...
OBJECTIVE: To explore preferences in the management of patients with newly diagnosed high-risk prost...
BACKGROUND: High-quality management of prostate cancer is needed in the fields of clinics, research,...
The widely recognised benefits of a multidisciplinary approach to treating cancer may be particularl...
The Prostate Cancer Programme of the European School of Oncology developed the concept of specialise...
The Prostate Cancer Programme of the European School of Oncology developed the concept of specialise...
The Prostate Cancer Programme of the European School of Oncology developed the concept of specialise...
CONTEXT: Phase 3 trials have made major contributions to advances in prostate cancer (PCa). However,...
Background: Multidisciplinary care of prostate cancer is increasingly offered in specialised cancer ...
CONTEXT: Phase 3 trials have made major contributions to advances in prostate cancer (PCa). However...
Background: There is uncertainty in deferred active treatment (DAT) programmes, regarding patient s...
BACKGROUND: There is uncertainty in deferred active treatment (DAT) programmes, regarding patient se...
Background: ECCO Essential Requirements for Quality Cancer Care (ERQCC) are written by experts repre...
Multidisciplinary care of prostate cancer is increasingly offered in specialised cancer centres. It ...
BACKGROUND: In advanced prostate cancer (APC), successful drug development as well as advances in im...
Multidisciplinary care of prostate cancer is increasingly offered in specialised cancer centres. It ...
OBJECTIVE: To explore preferences in the management of patients with newly diagnosed high-risk prost...